Kingsview Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$898K Buy
7,422
+150
+2% +$18.2K 0.02% 613
2025
Q1
$811K Sell
7,272
-178
-2% -$19.8K 0.02% 598
2024
Q4
$725K Sell
7,450
-224
-3% -$21.8K 0.01% 637
2024
Q3
$883K Sell
7,674
-702
-8% -$80.7K 0.02% 568
2024
Q2
$892K Sell
8,376
-670
-7% -$71.3K 0.02% 542
2024
Q1
$875K Buy
9,046
+517
+6% +$50K 0.02% 532
2023
Q4
$861K Sell
8,529
-426
-5% -$43K 0.03% 509
2023
Q3
$912K Buy
8,955
+787
+10% +$80.2K 0.03% 460
2023
Q2
$824K Buy
8,168
+1,077
+15% +$109K 0.03% 466
2023
Q1
$652K Sell
7,091
-602
-8% -$55.4K 0.03% 503
2022
Q4
$698K Buy
7,693
+182
+2% +$16.5K 0.03% 423
2022
Q3
$571K Sell
7,511
-165
-2% -$12.5K 0.03% 467
2022
Q2
$649K Buy
7,676
+1,871
+32% +$158K 0.03% 481
2022
Q1
$509K Sell
5,805
-1,934
-25% -$170K 0.02% 567
2021
Q4
$677K Sell
7,739
-331
-4% -$29K 0.03% 498
2021
Q3
$660K Buy
8,070
+311
+4% +$25.4K 0.03% 482
2021
Q2
$711K Buy
7,759
+840
+12% +$77K 0.04% 466
2021
Q1
$596K Buy
6,919
+762
+12% +$65.6K 0.03% 471
2020
Q4
$581K Sell
6,157
-212
-3% -$20K 0.04% 415
2020
Q3
$554K Sell
6,369
-1,131
-15% -$98.4K 0.05% 345
2020
Q2
$655K Sell
7,500
-4,266
-36% -$373K 0.07% 275
2020
Q1
$970K Buy
11,766
+5,017
+74% +$414K 0.13% 182
2019
Q4
$639K Buy
6,749
+969
+17% +$91.7K 0.08% 244
2019
Q3
$502K Buy
5,780
+304
+6% +$26.4K 0.08% 253
2019
Q2
$500K Sell
5,476
-1,252
-19% -$114K 0.08% 247
2019
Q1
$580K Buy
6,728
+1,081
+19% +$93.2K 0.09% 242
2018
Q4
$434K Buy
5,647
+66
+1% +$5.07K 0.09% 231
2018
Q3
$431K Sell
5,581
-1,983
-26% -$153K 0.09% 240
2018
Q2
$512K Sell
7,564
-56
-0.7% -$3.79K 0.12% 192
2018
Q1
$552K Buy
7,620
+712
+10% +$51.6K 0.14% 192
2017
Q4
$520K Buy
6,908
+3,085
+81% +$232K 0.19% 167
2017
Q3
$294K Buy
3,823
+896
+31% +$68.9K 0.13% 214
2017
Q2
$219K Buy
+2,927
New +$219K 0.11% 229